# Bioequivalence of Lamnet (Lamotrigine)100mg Tablet With the Reference Product Lamictal 100mg (Lamotrigine) Tablet Under Fasting Conditions

> **NCT04938856** · PHASE1 · COMPLETED · sponsor: **University of Karachi** · enrollment: 26 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Lamotrigine tablet

## Key facts

- **NCT ID:** NCT04938856
- **Lead sponsor:** University of Karachi
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-04
- **Primary completion:** 2020-09-24
- **Final completion:** 2020-10-25
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2022-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04938856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04938856, "Bioequivalence of Lamnet (Lamotrigine)100mg Tablet With the Reference Product Lamictal 100mg (Lamotrigine) Tablet Under Fasting Conditions". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04938856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*